Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator-activated receptor-alpha (PPARalpha) agonists such as fenofibrate are used to treat dyslipidemia. Although fenofibrate is considered safe in humans, it is known to cause hepatocarcinogenesis in rodents. To evaluate untargeted metabolic profiling as a tool for gaining insight into the underlying pharmacology and hepatotoxicology, Fischer 344 male rats were dosed with 300 mg/kg/day of fenofibrate for 14 days and the urine and plasma were analyzed on days 2 and 14. A combination of liquid and gas chromatography mass spectrometry returned the profiles of 486 plasma and 932 urinary metabolites. Aside from known pharmacological effects, such as accelerated fatty acid beta-oxidation and reduced plasma cholesterol, new observations on the drug's impact on cellular metabolism were generated. Reductions in TCA cycle intermediates and biochemical evidence of lactic acidosis demonstrated that energy metabolism homeostasis was altered. Perturbation of the glutathione biosynthesis and elevation of oxidative stress markers were observed. Furthermore, tryptophan metabolism was up-regulated, resulting in accumulation of tryptophan metabolites associated with reactive oxygen species generation, suggesting the possibility of oxidative stress as a mechanism of nongenotoxic carcinogenesis. Finally, several metabolites related to liver function, kidney function, cell damage, and cell proliferation were altered by fenofibrate-induced toxicity at this dose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786 · cited 5×
“PPARa is abundantly expressed in the liver (Auboeuf et al. 1997; Braissant et al. 1996) and is a member of the PPAR subfamily of the nuclear hormone receptors (Berger and Moller 2002; Staels et al. 1998).”
BackgroundInfluentialThe Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 982
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
Lee, C.-H., Olson, P., & Evans, R. M. (2003) · Endocrinology · doi:10.1210/en.2003-0288 · Cited by 890
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
Analysis of the Adult Human Plasma Metabolome
Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., Evans, A. M., Guo, L., Hanson, R. W., Kalhan, S. C., Ryals, J. A., & Milburn, M. V. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.4.383 · Cited by 490 · cited 3×
“Data Imputation and Statistical Analysis: After the data were corrected for minor variation resulting from instrument interday tuning differences (Lawton et al. 2008), the missing values for a given biochemical were imputed with half the observed minimum on the assumption that they were below the limits of detection.”
MethodInfluentialSelf-citationSas, K., Robotka, H., Toldi, J., & Vécsei, L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.033 · Cited by 463
Sydow, K., & Münzel, T. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00033-3 · Cited by 433
Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425
Safety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408
Processing methods for differential analysis of LC/MS profile data
Katajamaa, M., & Orešič, M. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-179 · Cited by 400
Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313
Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., & Gonzalez, F. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00317-07 · Cited by 255
Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?
Peters, J. M., Cheung, C., & Gonzalez, F. J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0678-9 · Cited by 248
Dietschy, J. M. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.2.444s · Cited by 247
Wiener klinische Wochenschrift
(2013) · Wiener klinische Wochenschrift · doi:10.1007/508.1613-7671 · Cited by 229
Seidel, A., Brunner, S., SEIDEL, P. R., Fritz, G., & Herbarth, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603164 · Cited by 157
Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism
Fruchart, J.-C., & Duriez, P. (2006) · Drugs of Today · doi:10.1358/dot.2006.42.1.963528 · Cited by 132
Diagnositic value of serum bile acid estimations in liver disease.
Barnes, S., Gallo, G., Trash, D. B., & Morris, J. S. (1975) · Journal of Clinical Pathology · doi:10.1136/jcp.28.6.506 · Cited by 131
Muoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129 · cited 1×
“Interestingly, our observation of reduced TCA cycle intermediates is similar to that observed in lipid-induced insulin resistance in skeletal muscle (Koves et al. 2008; Muoio and Koves 2007).”
Connor, S. C., Wu, W. B., Sweatman, B. C., et al. (2004) · Biomarkers · doi:10.1080/13547500410001720767 · Cited by 111
Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Žitňanová, I., Korytár, P., Aruoma, O. I., Šustrová, M., Garaiová, I., Muchová, J., Kalnovičová, T., Pueschel, S., & Ďuračková, Z. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.11.020 · Cited by 96
Kumps, A. H., Duez, P., & Mardens, Y. (2002) · PubMed · Cited by 96
Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise
Hellsten, Y., Svensson, M., Sjödin, B., Smith, S., Christensen, A. S., Richter, E. A., & Bangsbo, J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00631-1 · Cited by 89
Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver
Cariello, N. F., Romach, E. H., Colton, H. M., Ni, H., Yoon, L., Falls, J. G., Casey, W., Creech, D., Anderson, S. P., Benavides, G. R., et al. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi273 · Cited by 77
RNA metabolism in uremic patients: Accumulation of modified ribonucleosides in uremic serum
Niwa, T., Takeda, N., & Yoshizumi, H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00944.x · Cited by 76
Markaverich, B. M., Gregory, R. R., Alejandro, M. A., Clark, J. H., Johnson, G. A., & Middleditch, B. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68628-4 · Cited by 74
Hoivik, D. J., Qualls, C. W., Mirabile, R. C., Cariello, N. F., Kimbrough, C. L., Colton, H. M., Anderson, S. P., Santostefano, M. J., Morgan, R. J. O., Dahl, R. R., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh182 · Cited by 73
Long, C. L., Dillard, D. R., Bodzin, J. H., Geiger, J. W., & Blakemore, W. S. (1988) · Metabolism · doi:10.1016/0026-0495(88)90118-7 · Cited by 71
Diacetylated Derivatives of Spermine and Spermidine as Novel Promising Tumor Markers
Kawakita, M., & Hiramatsu, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj068 · Cited by 70
Guo, L., Fang, H., Collins, J., Fan, X.-H., Dial, S., Wong, A., Mehta, K., Blann, E., Shi, L., Tong, W., et al. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-s2-s18 · Cited by 69
Self-citationTamura, K., Ono, A., Miyagishima, T., Nagao, T., & Urushidani, T. (2006) · The Journal of Toxicological Sciences · doi:10.2131/jts.31.471 · Cited by 68
The mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism
Fruchart, J., & Duriez, P. (2006) · Drugs of today · doi:10.1358/dot.2006.42.1.893618 · Cited by 64
Fibrates: What Have We Learned in the Past 40 Years?
Backes, J. M., Gibson, C. A., Ruisinger, J. F., & Moriarty, P. M. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.412 · Cited by 63
Tryptophan, adenosine, neurodegeneration and neuroprotection
Stone, T. W., Forrest, C. M., Mackay, G., Stoy, N. S., & Darlington, L. G. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9064-3 · Cited by 61
Nishimura, J., Dewa, Y., Muguruma, M., Kuroiwa, Y., Yasuno, H., Shima, T., Jin, M., Takahashi, M., Umemura, T., & Mitsumori, K. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm011 · Cited by 56
Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats
Nishimura, J., Dewa, Y., Okamura, T., Muguruma, M., Jin, M., Saegusa, Y., Umemura, T., & Mitsumori, K. (2008) · Archives of Toxicology · doi:10.1007/s00204-007-0278-2 · Cited by 49
Profiling of hepatic gene expression in rats treated with fibric acid analogs
Cornwell, P. D., Souza, A. T. D., & Ulrich, R. G. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.12.019 · Cited by 48
Molecular basis of renal disease. Mechanisms and clinical significance of cell volume regulation
Waldegger, S., Steuer, S., Risler, T., et al. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.4.867 · Cited by 48
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk
Linton, M. F., & Fazio, S. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0092-2 · Cited by 47
Delaney, J., Hodson, M. P., Thakkar, H., Connor, S. C., Sweatman, B. C., Kenny, S. P., McGill, P., Holder, J. C., Hutton, K. A., Haselden, J. N., et al. (2004) · Archives of Toxicology · doi:10.1007/s00204-004-0625-5 · Cited by 46
Peroxisome-Proliferator Regulates Key Enzymes of the Tryptophan-NAD+ Pathway
Shin, M., Ohnishi, M., Iguchi, S., Sano, K., & Umezawa, C. Y. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8683 · Cited by 43
Receptor‐Mediated Hepatocarcinogenesis: Role of Hepatocyte Proliferation and Apoptosis
Oliver, J. D., & Roberts, R. A. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910101.x · Cited by 42
Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use
Holoshitz, N., Alsheikh-Ali, A. A., & Karas, R. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.057 · Cited by 40 · cited 2×
“Hepatocarcinogenesis aside, various adverse effects (although low in frequency) have been reported, such as liver cirrhosis, abnormal liver function, muscle myopathy, and renal disorders (Davidson et al. 2007; Holoshitz, Alsheikh-Ali, and Karas 2008; Tahmaz et al. 2007).”
BackgroundShin, M., Kim, I., Inoue, Y., Kimura, S., & Gonzalez, F. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026294 · Cited by 38
Expert Commentary: The Safety of Fibrates in Lipid-Lowering Therapy
Brown, W. V. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.017 · Cited by 35
Moffit, J. S., Koza‐Taylor, P., Holland, R. D., Thibodeau, M. S., Beger, R. D., Lawton, M. P., & Manautou, J. E. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.04.008 · Cited by 33
Proteomic characterization of the effects of clofibrate on protein expression in rat liver
Léonard, J., Courcol, M., Mariet, C., Charbonnier, A., Boitier, E., Duchesne, M., Parker, F., Genêt, B., Supatto, F., Roberts, R. A., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200500251 · Cited by 30
Draye, J., Veitch, K., Vamecq, J., & HOOF, F. V. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14442.x · Cited by 29
Acute Renal Failure Secondary to Fenofibrate Monotherapy-Induced Rhabdomyolysis
Tahmaz, M., Kumbasar, A., Ergen, K., Üre, Ü., Karatemiz, G., & Kazancıoğlu, R. (2007) · Renal Failure · doi:10.1080/08860220701573640 · Cited by 22
Wheelock, C. E., Goto, S., Hammock, B. D., & Newman, J. W. I. (2007) · Metabolomics · doi:10.1007/s11306-007-0052-8 · Cited by 21
Mortensen, P. B. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90338-3 · Cited by 17
Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease
Caestecker, J. S. D., Jazrawi, R. P., Nisbett, J. A., et al. (1995) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199510000-00009 · Cited by 15
Clinical significance of cell volume regulation
Feng, Y., Müller, V., Friedrich, B., et al. (2001) · Max Planck Institute for Plasma Physics · Cited by 9
Research works printed but not linked: 2
- Kumps A, 2002, Clin Chem, 48, 708
- Lawrence JW, 1998, Toxicology of the Liver, 125
Cited by
Human metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017
Self-citationLee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.-J., Mehta, H., Hevener, A. L., de Cabo, R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.009 · Cited by 715
“Notably, AMPK activation occurred despite lower AMP levels and higher ADP and ATP levels (Figure S2D) similar to that achieved by salicylate (Hashiguchi and Zhang-Akiyama, 2009), leptin (Ohta et al., 2009), and metformin (Fujii et al., 2006).”
Organization of GC/MS and LC/MS metabolomics data into chemical libraries
DeHaven, C. D., Evans, A. M., Dai, H., & Lawton, K. A. (2010) · Journal of Cheminformatics · doi:10.1186/1758-2946-2-9 · Cited by 601
Rudd, J. J., Kanyuka, K., Hassani-Pak, K., Derbyshire, M., Andongabo, A., Devonshire, J., Lysenko, A., Saqi, M., Desai, N. M., Powers, S. J., et al. (2015) · Plant Physiology · doi:10.1104/pp.114.255927 · Cited by 302
“These platforms have been described in detail in previous publications (Evans et al., 2009; Ohta et al., 2009).”
MethodMetabolic Signatures of Bacterial Vaginosis
Srinivasan, S., Morgan, M. T., Fiedler, T. L., Djukovic, D., Hoffman, N. G., Raftery, D., Marrazzo, J. M., & Fredricks, D. N. (2015) · mBio · doi:10.1128/mbio.00204-15 · Cited by 303
Metadata
- Authors
- Ohta, T., Masutomi, N., Tsutsui, N., Sakairi, T., Mitchell, M., Milburn, M. V., Ryals, J. A., Beebe, K. D., & Guo, L.
- Affiliations
- Tanabe Pharma Corporation (Japan) (JP)
- Metabolon (United States) (US)
- Corresponding author
- Guo, Lining
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2009-05-20
- Volume
- 37
- Issue
- 4
- Pages
- 521-535
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2134296519
- Cited by
- 213
- References
- 57
- Citations by year
- 2026: 5 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 8 · 2020: 11 · 2019: 15 · 2018: 14 · 2017: 14 · 2016: 22 · 2015: 18 · 2014: 27 · 2013: 15 · 2012: 24
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Toxicologic Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- fenofibrate, PPARα agonist, hepatotoxicity, hepatocarcinogenesis, untargeted metabolomics, urinary metabolites, plasma metabolites, fatty acid beta-oxidation, TCA cycle intermediates, lactic acidosis, energy metabolism, glutathione synthesis, oxidative stress, tryptophan metabolism, reactive oxygen species, non-genotoxic carcinogenesis, drug-induced liver injury, F344 rats
- MeSH terms
- Acidosis, Lactic, Animals, Hypolipidemic Agents, Chromatography, Liquid, Citric Acid Cycle, Fatty Acids, Liver, Male, Gas Chromatography-Mass Spectrometry, Fenofibrate, Rats, Inbred F344, Tryptophan, Biomarkers, Oxidative Stress, Toxicity Tests, Chronic, PPAR alpha, Lipid Metabolism, Rats, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.